# Latigo Biotherapeutics (LTGO) — News

LTGO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ltgo/news

## Recent headlines

- [Bio-pharmaceutical stocks rose in after-hours trading, with LTGO up 2%, RDGT gaining 1.4% and MGX rising 1.5%.](https://www.ainvest.com/news/bio-pharmaceutical-stocks-rose-hours-trading-ltgo-2-rdgt-gaining-1-4-mgx-rising-1-5-2610-83) — AInvest Wire, Oct 14, 2026
- [L&T to report Q2 results on Oct. 27](https://www.ainvest.com/news/report-q2-results-oct-27-2610) — AInvest Wire, Oct 13, 2026
- [Latigo Biotherapeutics, Inc.: Leerink partners initiates coverage with outperform rating; target price $36](https://www.ainvest.com/news/latigo-biotherapeutics-leerink-partners-initiates-coverage-outperform-rating-target-price-36-2609) — AInvest Wire, Sep 1, 2026
- [Latigo Biopharma indicated to open at $22, IPO price $18](https://www.ainvest.com/news/latigo-biopharma-open-22-ipo-price-18-2608) — AInvest Wire, Aug 7, 2026
  Latigo Biopharma’s shares opened at $22 on the Nasdaq on August 7, 2026, surpassing the initial offering price of $18 per share. The biotechnology firm raised $345.6 million through the sale of 19.2 million shares, marking a strong market reception for its initial public offering. The company’s…
- [Latigo said to allocate zero shares to 70% of IPO orders](https://www.ainvest.com/news/latigo-allocate-shares-70-ipo-orders-2608) — AInvest Wire, Aug 7, 2026
  Latigo Bio, a biotechnology company preparing for an initial public offering (IPO), has reportedly allocated zero shares to 70% of IPO orders, according to recent filings and industry reports. This allocation strategy has raised questions among investors about the company’s approach to distributing…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).